Evidence map›Paper›PMID 33919060›Full record

ReviewVaccines2021

Advances in

Ki-Back Chu, Fu-Shi Quan

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 78 citations in OpenAlex.

  1. Live-attenuatedVirulence · 2026
    Article
  2. Article
  3. ROP64-DeficientMicroorganisms · 2026
    Article
  4. Article
  5. Article
  6. Advances and Translational Challenges inVeterinary sciences · 2026
    Review
  7. Protection AgainstPharmaceutics · 2026
    Article
  8. Review
  9. Evolution ofJournal of parasitology research · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Influenza virus-like particles presentingNanomedicine (London, England) · 2025
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Prophylactic Effect of Microwave Radiation onJournal of parasitology research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ki-Back ChuDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Korea.
Fu-Shi QuanMedical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0003-0419-9339
Kyung Hee University · KR

Funding

Ministry of Health & Welfare, Republic of Korea HV20C0085, HV20C0142National Research Foundation of Korea (NRF) 2018R1A6A1A03025124
6 · The paper itself

Abstract

Toxoplasmosis, caused by the apicomplexan parasite

Indexed as

immune responseprotectionToxoplasma gondiivaccine

Identifiers

PMID33919060
PMCPMC8143161
OpenAlexW3152765551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.